Isida Byku

Mar 1, 2024 | acc.org | Isida Byku

Cardiology Magazine Font Size A A A Hypertrophic septum affects patients in two ways: it manifests as symptomatic left ventricular outflow (LVOT) obstruction in hypertrophic cardiomyopathy (HCM) or prevents the option for transcatheter mitral valve replacement (TMVR) due to the perceived risk of developing LVOT obstruction. Surgical myectomy has long been the treatment of choice for achieving septal reduction.

Jan 16, 2024 | ahajournals.org | Michael O’Byrne |Isida Byku

AbstractExport CitationsPDF/EPUB BACKGROUND: Lower-limb amputation rates in patients with chronic limb-threatening ischemia vary across the United States, with marked disparities in amputation rates by gender, race, and income status. We evaluated the association of patient, hospital, and geographic characteristics with the intensity of vascular care received the year before a major lower-limb amputation and how intensity of care associates with outcomes after amputation.

Oct 17, 2023 | ahajournals.org | Isida Byku

AbstractExport CitationsPDF/EPUB BACKGROUND: Coronary intravascular lithotripsy (IVL) safely facilitates successful stent implantation in severely calcified lesions. This analysis sought to determine the relative impact of lesion calcium eccentricity on the safety and effectiveness of IVL using high-resolution optical coherence tomography imaging.

Aug 23, 2023 | ahajournals.org | Isida Byku

AbstractExport CitationsPDF/EPUB BACKGROUND: In the COMPLETE trial (Complete Versus Culprit-Only Revascularization to Treat Multivessel Disease After Early PCI for STEMI), a strategy of complete revascularization reduced the risk of major cardiovascular events compared with culprit-lesion-only percutaneous coronary intervention in patients presenting with ST-segment–elevation myocardial infarction (STEMI) and multivessel coronary artery disease.

Jul 1, 2023 | acc.org | Isida Byku

Font Size A A A Moderate or more aortic insufficiency (AI) has a prevalence of 1.6% in persons over 65 years.1 Surgical aortic valve replacement (SAVR) has long been the gold standard for treating AI. However, aortic valve replacement has been shown to be underutilized in this population.